OmniAb Inc

OmniAb insiders keep buying during RSU vesting, signaling long‑term confidence despite a downtrend. Investors learn insider activity reflects routine equity plans, not market swings.

Insider buying by OmniAb’s Chief Legal Officer shows confidence in its therapeutic antibody platform, while frequent small trades suggest liquidity‑focused management rather than price‑moving bets.